Is the Options Market Predicting a Spike in Aldeyra Therapeutics (ALDX) Stock?

Zacks Dec 9 09:15 ET

Positive Outlook for Aldeyra Therapeutics: Buy Rating Backed by Promising Reproxalap Prospects and Strategic Partnership With AbbVie

TipRanksDec 9 06:32 ET · Ratings

Aldeyra Therapeutics to Participate in the Citi 2024 Global Healthcare Conference

Aldeyra TherapeuticsDec 2 00:00 ET

ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap

Zacks Nov 19 09:35 ET

The FDA has accepted aldeyra therapeutics' (ALDX.US) application for market approval of a potential "first-in-class" therapy for dry eye disease.

Aldeyra Therapeutics (ALDX.US) announced that the USA FDA has accepted its resubmitted New Drug Application (NDA) for reproxalap, an innovative ophthalmic drug for the treatment of dry eye disease.

Zhitong FinanceNov 19 07:33 ET

BTIG Maintains Aldeyra Therapeutics(ALDX.US) With Buy Rating, Maintains Target Price $11

Moomoo NewsNov 19 03:36 ET · Ratings